Blog
ImmuCell Upgraded to Outperform on Sales Surge & FDA Upside
ImmuCell Corporation ICCC has received a recommendation upgrade to “Outperform,” driven by consistent execution across its sales and gross margin profile, alongside emerging strategic optionality
Super Micro Computer's HPC Solutions Propel Server Growth: What's Next?
Super Micro Computer’s SMCI server and storage segment has experienced massive traction in recent times. The recent growth has primarily been fueled by demand in high performance computing (HPC) and
Zacks Initiates Coverage of Blue Ridge Bankshares With Outperform Recommendation
Zacks Investment Research has recently initiated coverage of Blue Ridge Bankshares, Inc. BRBS, assigning an "Outperform" recommendation to the company's shares. This bullish stance reflects the
AGNC Investment Q2 Earnings Miss Estimates, Book Value Declines Y/Y
AGNC Investment Corp.’s AGNC second-quarter 2025 net spread and dollar roll income per common share (excluding estimated "catch-up" premium amortization benefit) of 38 cents missed the Zacks
JNJ Seeks FDA Approval for Oral Psoriasis Drug Icotrokinra
Johnson & Johnson JNJ announced that it has submitted a new drug application (NDA) to the FDA seeking approval for its investigational oral peptide, icotrokinra, for treating moderate-to-severe
3 Reasons Why Investors Should Stay Away From Alibaba Stock Right Now
Alibaba Group BABA presents a concerning investment picture that should give potential investors serious pause. While the Chinese e-commerce giant reported revenue growth of 7% year over year to
Will Nasdaq Pull Off a Surprise This Earnings Season?
Nasdaq, Inc. NDAQ is expected to register an improvement in its top and bottom lines when it reports second-quarter 2025 results on July 24, before the opening bell.The Zacks Consensus Estimate for
Is on! the Bright Spot in Altria's Oral Tobacco Portfolio?
Altria Group, Inc.’s MO on! nicotine pouch brand continues to outperform in an increasingly competitive marketplace, serving as a rare growth engine within its oral tobacco segment. While
Bank OZK (OZK) Could Be a Great Choice
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But when you're an income investor, your primary focus is
Independent Bank Corp. (INDB) Could Be a Great Choice
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is
AZN Commits USD50B to US Manufacturing Expansion Amid Tariff Pressures
AstraZeneca AZN has unveiled a sweeping $50 billion investment plan in the United States, to be executed by 2030. The initiative is expected to significantly generate skilled jobs across the country
What Should Investors Expect From Carter's Ahead of Q2 Earnings?
Carter's, Inc. CRI is scheduled to release second-quarter 2025 results on July 25, before the opening bell. The branded marketer of apparel exclusively for babies and children in North America is
DKILY vs. HOCPY: Which Stock Should Value Investors Buy Now?
Investors interested in Electronics - Miscellaneous Products stocks are likely familiar with Daikin Industries (DKILY) and Hoya Corp. (HOCPY). But which of these two stocks presents investors with
PFGC or SFM: Which Is the Better Value Stock Right Now?
Investors with an interest in Food - Natural Foods Products stocks have likely encountered both Performance Food Group (PFGC) and Sprouts Farmers (SFM). But which of these two stocks offers value
NVST or ABT: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Products sector might want to consider either Envista (NVST) or Abbott (ABT). But which of these two stocks presents investors with the better value
LNW or DKNG: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Gaming sector have probably already heard of Light & Wonder (LNW) and DraftKings (DKNG). But which of these two companies is the best option for those looking
PAGS vs. CPAY: Which Stock Is the Better Value Option?
Investors interested in Financial Transaction Services stocks are likely familiar with PagSeguro Digital Ltd. (PAGS) and Corpay (CPAY). But which of these two stocks presents investors with the
TD vs. IBN: Which Stock Should Value Investors Buy Now?
Investors interested in Banks - Foreign stocks are likely familiar with Toronto-Dominion Bank (TD) and ICICI Bank Limited (IBN). But which of these two stocks presents investors with the better
Implied Volatility Surging for American Financial Stock Options
Investors in American Financial Group, Inc. AFG need to pay close attention to the stock based on moves in the options market lately. That is because the Sept. 19, 2025 $78.00 Put had some of the
GameStop Recovery Hinges on US Strength as Global Woes Continue
GameStop Corp. GME delivered mixed regional results in the first quarter of fiscal 2025, as strength in the United States was overshadowed by continued weakness in international markets. Total net
Crown Holdings Q2 Earnings & Revenues Beat Estimates, '25 View Raised
Crown Holdings, Inc. CCK reported second-quarter 2025 adjusted earnings per share (EPS) of $2.15, beating the Zacks Consensus Estimate of $1.86. The bottom line exceeded the company’s EPS guidance
Slowdown in Leveraged Loan Issuance to Hurt Moody's Q2 Earnings
Moody's MCO is scheduled to announce second-quarter 2025 results on July 23, before the opening bell. The company’s Corporate Finance line, the largest revenue contributor at the Moody's Investors
Expanding Clientele Aids Snowflake's Prospects: What's the Path Ahead?
Snowflake SNOW is strengthening its position in enterprise data infrastructure, as demand accelerates for AI-led analytics, collaboration and scalable compute. The company’s usage-based model
Boston Beer's Q2 Earnings on Horizon: What Surprise Awaits Investors?
The Boston Beer Company, Inc. (SAM) is likely to register growth in its top line when it reports second-quarter 2025 results on July 24. The company’s bottom line is expected to have declined year
KeyCorp's Q2 Earnings Beat Estimates, NII & Fee Income Rise Y/Y
KeyCorp’s KEY second-quarter 2025 earnings per share from continuing operations of 35 cents surpassed the Zacks Consensus Estimate by a penny. The bottom line reflected a 40% jump from the


